company background image
OMIC logo

Singular Genomics Systems NasdaqCM:OMIC Stock Report

Last Price

US$21.68

Market Cap

US$54.1m

7D

-4.7%

1Y

76.3%

Updated

21 Nov, 2024

Data

Company Financials +

Singular Genomics Systems, Inc.

NasdaqCM:OMIC Stock Report

Market Cap: US$54.1m

OMIC Stock Overview

A life science technology company, develops next generation sequencing and spatial multiomics technology for researchers and clinicians to advance science and medicine. More details

OMIC fundamental analysis
Snowflake Score
Valuation1/6
Future Growth2/6
Past Performance0/6
Financial Health4/6
Dividends0/6

Singular Genomics Systems, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Singular Genomics Systems
Historical stock prices
Current Share PriceUS$21.68
52 Week HighUS$23.41
52 Week LowUS$5.34
Beta1.51
11 Month Change53.32%
3 Month Change241.96%
1 Year Change76.26%
33 Year Change-94.73%
5 Year Changen/a
Change since IPO-97.19%

Recent News & Updates

Recent updates

Singular Genomics cut to Neutral at UBS on delays for sequencer shipments

Aug 17

Singular Genomics Systems GAAP EPS of -$0.34

Aug 09

Shareholder Returns

OMICUS Life SciencesUS Market
7D-4.7%-7.2%-1.2%
1Y76.3%1.2%30.4%

Return vs Industry: OMIC exceeded the US Life Sciences industry which returned 1.2% over the past year.

Return vs Market: OMIC exceeded the US Market which returned 30.4% over the past year.

Price Volatility

Is OMIC's price volatile compared to industry and market?
OMIC volatility
OMIC Average Weekly Movement39.5%
Life Sciences Industry Average Movement8.8%
Market Average Movement6.2%
10% most volatile stocks in US Market15.5%
10% least volatile stocks in US Market3.1%

Stable Share Price: OMIC's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: OMIC's weekly volatility has increased from 23% to 39% over the past year.

About the Company

FoundedEmployeesCEOWebsite
2016255Drew Spaventawww.singulargenomics.com

Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and spatial multiomics technology for researchers and clinicians to advance science and medicine. The company is involved in the developing of G4, consisting of G4 instrument and associated consumables for various applications, such as max read kits for single cell sequencing, rare variant detection with high-definition sequencing, gene fusion detection with ring-seq, and extended range sequencing; and PX instrument and associated consumables focusing on the single cell and spatial analysis markets. Singular Genomics Systems, Inc. was incorporated in 2016 and is based in San Diego, California.

Singular Genomics Systems, Inc. Fundamentals Summary

How do Singular Genomics Systems's earnings and revenue compare to its market cap?
OMIC fundamental statistics
Market capUS$54.11m
Earnings (TTM)-US$86.32m
Revenue (TTM)US$2.67m

20.3x

P/S Ratio

-0.6x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
OMIC income statement (TTM)
RevenueUS$2.67m
Cost of RevenueUS$4.02m
Gross Profit-US$1.35m
Other ExpensesUS$84.97m
Earnings-US$86.32m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-34.59
Gross Margin-50.77%
Net Profit Margin-3,236.67%
Debt/Equity Ratio8.4%

How did OMIC perform over the long term?

See historical performance and comparison